Techno Drugs Ltd. (DSE:TECHNODRUG)
Bangladesh
· Delayed Price · Currency is BDT 28.80
+1.00 (3.60%)
At close: Mar 9, 2026
Techno Drugs Balance Sheet
Financials in millions BDT. Fiscal year is July - June.
Millions BDT. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
| Cash & Equivalents | 357.3 | 434.34 | 321.08 | 34.47 | 139.94 |
| Short-Term Investments | 7.07 | 6.76 | 47.34 | 53.22 | 30.6 |
| Cash & Short-Term Investments | 364.37 | 441.1 | 368.42 | 87.69 | 170.53 |
| Cash Growth | -17.24% | 19.73% | 320.15% | -48.58% | - |
| Accounts Receivable | 1,251 | 1,141 | 958.96 | 789.71 | 707.18 |
| Other Receivables | - | 41.04 | 41.04 | 41.04 | 41.04 |
| Receivables | 1,251 | 1,182 | 1,000 | 830.76 | 748.22 |
| Inventory | 1,023 | 1,104 | 856.87 | 939.14 | 646.64 |
| Prepaid Expenses | - | - | 4.54 | 5.55 | 4.27 |
| Other Current Assets | 789.94 | 733.96 | 397.74 | 352.6 | 299.12 |
| Total Current Assets | 3,428 | 3,461 | 2,628 | 2,216 | 1,869 |
| Property, Plant & Equipment | 4,135 | 3,842 | 3,869 | 3,818 | 3,492 |
| Long-Term Investments | 0.27 | 0.27 | 0.27 | 0.27 | 0.27 |
| Other Intangible Assets | 7.48 | 6.45 | 6.39 | 7.22 | 3.09 |
| Other Long-Term Assets | 0 | 0 | - | - | - |
| Total Assets | 7,571 | 7,309 | 6,503 | 6,041 | 5,364 |
| Accounts Payable | 153.15 | 41.98 | 76.72 | 78.06 | 65.92 |
| Accrued Expenses | 81.22 | 173.37 | 155.74 | 186.26 | 148.25 |
| Short-Term Debt | 207.6 | 607.88 | 920.1 | 1,188 | 854.58 |
| Current Portion of Long-Term Debt | 59.65 | 377.18 | 509.8 | 414.02 | 474.44 |
| Current Portion of Leases | 30.05 | 44.87 | 40.78 | 27.76 | 21.27 |
| Current Income Taxes Payable | 256.61 | 239.3 | 179.1 | 215.27 | 162.21 |
| Current Unearned Revenue | - | 2.12 | 12.32 | 3.22 | - |
| Other Current Liabilities | 58.56 | 30.25 | 16.29 | 11.49 | 7.54 |
| Total Current Liabilities | 846.84 | 1,517 | 1,911 | 2,124 | 1,734 |
| Long-Term Debt | 2,406 | 1,560 | 1,212 | 1,056 | 973.76 |
| Long-Term Leases | 36.35 | 33.78 | 57.1 | 32.92 | 32.19 |
| Long-Term Deferred Tax Liabilities | 179.42 | 163.02 | 168.41 | 216.49 | 191.45 |
| Other Long-Term Liabilities | -0 | - | - | -0 | -0 |
| Total Liabilities | 3,469 | 3,273 | 3,348 | 3,429 | 2,932 |
| Common Stock | 1,320 | 1,320 | 941.57 | 941.57 | 941.57 |
| Additional Paid-In Capital | 621.59 | 621.59 | - | - | - |
| Retained Earnings | 1,673 | 1,607 | 1,464 | 1,183 | 987.83 |
| Comprehensive Income & Other | 487.44 | 487.44 | 748.98 | 487.44 | 502.99 |
| Shareholders' Equity | 4,102 | 4,036 | 3,154 | 2,612 | 2,432 |
| Total Liabilities & Equity | 7,571 | 7,309 | 6,503 | 6,041 | 5,364 |
| Total Debt | 2,740 | 2,623 | 2,740 | 2,718 | 2,356 |
| Net Cash (Debt) | -2,375 | -2,182 | -2,371 | -2,630 | -2,186 |
| Net Cash Per Share | -18.00 | -16.56 | -24.85 | -27.94 | -23.21 |
| Filing Date Shares Outstanding | 132 | 132 | 94.16 | 94.16 | 94.16 |
| Total Common Shares Outstanding | 132 | 132 | 94.16 | 94.16 | 94.16 |
| Working Capital | 2,581 | 1,944 | 716.73 | 91.79 | 134.58 |
| Book Value Per Share | 31.08 | 30.58 | 33.50 | 27.74 | 25.83 |
| Tangible Book Value | 4,094 | 4,030 | 3,148 | 2,605 | 2,429 |
| Tangible Book Value Per Share | 31.02 | 30.53 | 33.43 | 27.67 | 25.80 |
| Land | - | - | - | 770.52 | 769.57 |
| Buildings | - | - | - | 1,877 | 1,686 |
| Machinery | - | - | - | 2,353 | 2,050 |
| Construction In Progress | - | 97.26 | 132.73 | 179.88 | 49.64 |
Source: S&P Capital IQ. Standard template. Financial Sources.